A Randomized, Double-blind, Placebo-controlled Trial of Certolizumab Pegol in Women with Refractory Interstitial Cystitis/Bladder Pain Syndrome-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A Randomized, Double-blind, Placebo-controlled Trial of Certolizumab Pegol in Women with Refractory Interstitial Cystitis/Bladder Pain Syndrome

Published:2018-11 Issue:5 Volume:74 Page:623-630
ISSN:0302-2838
Container-title:European Urology
language:en
Short-container-title:European Urology

Author:

Bosch Philip C.

Publisher

Elsevier BV

Subject

Urology

Reference33 articles.

1. Psychosocial phenotyping in women with interstitial cystitis/painful bladder syndrome: a case control study;Nickel;J Urol,2010

2. Treatment choices, duration, and cost in patients with interstitial cystitis and painful bladder syndrome;Anger;Int Urogynecol J,2011

3. Alkalinized lidocaine and heparin provide immediate relief of pain and urgency in patients with interstitial cystitis;Parsons;J Sex Med,2012

4. Interstitial cystitis and systemic autoimmune diseases;Van de Merwe;Nat Clin Pract Urol,2007

5. Interstitial cystitis: unexplained associations with other chronic disease and pain syndromes;Alagiri;Urology,1997

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Pathomechanism and Current Treatments for Chronic Interstitial Cystitis and Bladder Pain Syndrome;Biomedicines;2024-09-10

2. Promising Experimental Treatment in Animal Models and Human Studies of Interstitial Cystitis/Bladder Pain Syndrome;International Journal of Molecular Sciences;2024-07-23

3. The efficacy and safety of monoclonal antibody therapies for interstitial cystitis/bladder pain syndrome: A meta‐analysis of randomized controlled trials;Neurourology and Urodynamics;2024-07-09

4. Synthesis and Biological Evaluation of Methoxypolyethylene-Glycol-Substituted Abiraterone Derivatives as Potential Antiprostate Cancer Agents;Molecular Pharmaceutics;2024-05-30

5. Current updates relating to treatment for interstitial cystitis/bladder pain syndrome: systematic review and network meta-analysis;BMC Urology;2024-04-24

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3